Publication | Closed Access

Successful treatment with brigatinib in a patient with ALK -rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung disease

Successful TreatmentMedicineLung AdenocarcinomaPathologyBronchial NeoplasmPulmonary FibrosisPulmonary BlastomaOncologyRadiation OncologyLung Cancer